Preservation of Brain Activity in Unresponsive Patients Identifies MCS Star
Objective Brain‐injured patients who are unresponsive at the bedside (ie, vegetative state/unresponsive wakefulness syndrome – VS/UWS) may present brain activity similar to patients in minimally conscious state (MCS). This peculiar condition has been termed “non‐behavioural MCS” or “MCS*”. In the pr...
Saved in:
Published in | Annals of neurology Vol. 90; no. 1; pp. 89 - 100 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article Web Resource |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.07.2021
Wiley Subscription Services, Inc Wiley John Wiley & Sons |
Subjects | |
Online Access | Get full text |
ISSN | 0364-5134 1531-8249 1531-8249 |
DOI | 10.1002/ana.26095 |
Cover
Summary: | Objective
Brain‐injured patients who are unresponsive at the bedside (ie, vegetative state/unresponsive wakefulness syndrome – VS/UWS) may present brain activity similar to patients in minimally conscious state (MCS). This peculiar condition has been termed “non‐behavioural MCS” or “MCS*”. In the present study we aimed to investigate the proportion and underlying brain characteristics of patients in MCS*.
Methods
Brain 18F‐fluorodeoxyglucose Positron Emission Tomography (FDG‐PET) was acquired on 135 brain‐injured patients diagnosed in prolonged VS/UWS (n = 48) or MCS (n = 87). From an existing database, relative metabolic preservation in the fronto‐parietal network (measured with standardized uptake value) was visually inspected by three experts. Patients with hypometabolism of the fronto‐parietal network were labelled “VS/UWS”, while its (partial) preservation either confirmed the behavioural diagnosis of “MCS” or, in absence of behavioural signs of consciousness, suggested a diagnosis of “MCS*”. Clinical outcome at 1‐year follow‐up, functional connectivity, grey matter atrophy, and regional brain metabolic patterns were investigated in the three groups (VS/UWS, MCS* and MCS).
Results
67% of behavioural VS/UWS presented a partial preservation of brain metabolism (ie, MCS*). Compared to VS/UWS patients, MCS* patients demonstrated a better outcome, global functional connectivity and grey matter preservation more compatible with the diagnosis of MCS. MCS* patients presented lower brain metabolism mostly in the posterior brain regions compared to MCS patients.
Interpretation
MCS* is a frequent phenomenon that is associated with better outcome and better brain preservation than the diagnosis of VS/UWS. Complementary exams should be provided to all unresponsive patients before taking medical decisions. ANN NEUROL 2021;90:89–100 |
---|---|
Bibliography: | Steven Laureys and Olivia Gosseries share the senior position. Aurore Thibaut and Rajanikant Panda have equally contributed. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 MSCA-RISE Human Brain Project SGA 3 scopus-id:2-s2.0-85107260267 |
ISSN: | 0364-5134 1531-8249 1531-8249 |
DOI: | 10.1002/ana.26095 |